SVAX Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 29

Employees

  • Latest Deal Type
  • Joint Venture

  • Investors
  • 2

SVAX General Information

Description

Operator of biopharmaceutical and vaccine production facilities intended for localizing manufacturing capacity. The company provides advanced research and development for therapeutic biologics and immunization agents and offers advisory support to local and international entities regarding market entry, enabling businesses to achieve supply chain independence, prepare for future health crises, and contribute to the growth of the domestic biotechnology sector in alignment with strategic national goals.

Contact Information

Website
www.svax.com.sa
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Prince Mohammed Ibn Abdulaziz Branch
  • Bin Hamran Towers (B), 5th Floor, Suite 510-B
  • Jeddah 23432
  • Saudi Arabia
Primary Industry
Other Healthcare Services
Other Industries
Drug Discovery
Pharmaceuticals
Other Pharmaceuticals and Biotechnology
Corporate Office
  • Prince Mohammed Ibn Abdulaziz Branch
  • Bin Hamran Towers (B), 5th Floor, Suite 510-B
  • Jeddah 23432
  • Saudi Arabia

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

SVAX Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Joint Venture 01-Jan-2016 Completed Generating Revenue
To view SVAX’s complete valuation and funding history, request access »

SVAX Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

SVAX Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
PnuVax Corporation Majority
UYC Corporate Venture Capital Majority
To view SVAX’s complete investors history, request access »

SVAX Investments (1)

SVAX’s most recent deal was a Joint Venture with Joint Venture (Shanghai Helius / SVAX). The deal was made on 07-Nov-2024.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Joint Venture (Shanghai Helius / SVAX) 07-Nov-2024 Joint Venture Pharmaceuticals
To view SVAX’s complete investments history, request access »

SVAX FAQs

  • When was SVAX founded?

    SVAX was founded in 2016.

  • Where is SVAX headquartered?

    SVAX is headquartered in Jeddah, Saudi Arabia.

  • What is the size of SVAX?

    SVAX has 29 total employees.

  • What industry is SVAX in?

    SVAX’s primary industry is Other Healthcare Services.

  • Is SVAX a private or public company?

    SVAX is a Private company.

  • What is SVAX’s current revenue?

    The current revenue for SVAX is .

  • Who are SVAX’s investors?

    PnuVax and UYC have invested in SVAX.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process